Trial site
Henry Ford Cancer Institute
- 18running trials
- 6closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Lung cancer13 trials
- Colorectal cancer5 trials
- Melanoma5 trials
- Acute myeloid leukaemia4 trials
- Head and neck cancer4 trials
- Bladder cancer3 trials
- Kidney cancer3 trials
- Multiple myeloma3 trials
- Childhood cancers2 trials
- Diffuse large B-cell lymphoma2 trials
- Gastric and oesophageal cancer2 trials
- Liver and biliary tract cancer2 trials
- and 17 more
- Phase
- Phase 1/210 trials
- Phase 18 trials
- Phase 35 trials
- Phase 21 trial
- Status
- Recruiting12 trials
- Active, not recruiting6 trials
- Completed3 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Nuvalent Inc.2 trials
- ABM Therapeutics Corporation1 trial
- ArriVent BioPharma, Inc.1 trial
- Daiichi Sankyo1 trial
- and 17 more
Running trials
Recruiting
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Recruiting
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Active, not recruiting
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Acute myeloid leukaemia2 recruiting
- Bladder cancer2 recruiting
- Childhood cancers2 recruiting
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Kidney cancer2 recruiting
- Melanoma2 recruiting
- Brain metastases1 recruiting
- Endometrial cancer1 recruiting
Closed trials
Completed
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
Terminated
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
Completed
Recruiting
Terminated
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026